Delivery Order SPE2DB20D1100-SPE2DB23FD8T8

Award Date 9/26/23
Potential Completion Date 9/27/23
Potential Value $17K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $1,843 delivery order contract to Amerisourcebergen Drug Corporation for 5 mg vials of the chemotherapy drug mitomycin. As a prime contractor for DLA's pharmaceutical supply program, Amerisourcebergen will deliver the vials to a customer located in Conshohocken, Pennsylvania. The firm fixed price order is for a one-day period of performance from July 25 to July 26, 2023, to fulfill a customer's near-term chemotherapy needs. No subcontractors or set aside...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $565 to Amerisourcebergen Drug Corporation to supply 4561985811 Mitomycin 5 mg vials. As the prime contractor, Amerisourcebergen will deliver the requested pharmaceutical products to a location in Conshohocken, Pennsylvania by August 30, 2023 under the terms of the order. The Defense Logistics Agency utilizes contracts such as this to efficiently procure necessary medical supplies for the U.S....
The Defense Logistics Agency awarded a $5,326 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562312732 units of 5 mg Mitomycin vials. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to its Conshohocken, Pennsylvania facility by September 27, 2023 to support the Defense Logistics Agency's medical supply needs. No subcontractors or set aside designations were identified. The delivery order was issued against an existing DLA...
The Defense Logistics Agency awarded a $337 firm fixed price delivery order contract to Amerisourcebergen Drug Corporation to provide 4562066016 Mitomycin 5 mg vials. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to a facility in Conshohocken, Pennsylvania by September 7, 2023 under the terms of the order. No subcontractors or set aside designations were specified. The Defense Logistics Agency supports Department of Defense procurement programs through...
Defense Logistics Agency, an agency of the Department of Defense, awarded a $10,800 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561406930 units of the chemotherapy drug mitomycin at 40 mg per vial. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in July 2023. The delivery order was issued under an existing Prime Vendor contract vehicle to supply pharmaceuticals and other medical commodities in...
The Defense Logistics Agency Troop Support Medical awarded a $545.67 delivery order contract to Amerisourcebergen Drug Corp Corporate Office Division for 4561934936 units of 5 mg Mitomycin vials. As the prime contractor, Amerisourcebergen Drug Corp will deliver the requested pharmaceutical products to the place of performance in Conshohocken, Pennsylvania within the firm fixed price and period of performance between August 24-25, 2023. The funding agency, DLA Troop Support Medical, supports...
The Defense Logistics Agency awarded a $6,085.47 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562179137 mitomycin 40 mg vials. The prime contractor will deliver the requested pharmaceutical products to a location in Conshohocken, Pennsylvania by September 15, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations and works to support all military services and combatant commands. This small order for cancer treatment...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,818.90, is for the delivery of Mitomycin 5 mg vials, a specialty cancer medication. The contract is a firm fixed-price, delivery order type with a completion date of May 30, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $30,000 to Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation. The order is for one gram vials of the chemotherapy drug methotrexate to be delivered to a facility in Conshohocken, Pennsylvania over a one-day period in August 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense globally, this award supports the Defense Logistics...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,751.36 firm fixed-price contract is for the supply of 5 mg vials of the drug mitomycin. The contract has an ultimate completion date of January 10, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB23FD8T8
    Delivery Order

The Defense Logistics Agency awarded a $17,126.50 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 40 mg vials of the chemotherapy drug mitomycin. Performance will take place in Conshohocken, Pennsylvania over one day in late September 2023. As a leading provider of pharmaceuticals and healthcare value-added services, Amerisourcebergen will deliver the requested chemotherapy product to support the Defense Department's medical readiness and treatment programs. No subcontractors or set aside designations were identified in the award information.

Generated 12/26/23, 9:51 AM